BioSpace News Archive

V-Bio Ventures (V-Bio) announces today the first closing of V-Bio Fund 2 with capital commitments of EUR 78 million (USD 95 million).

Precision Spine, Inc., a medical device company dedicated to Made-in-the-USA manufacturing, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Dakota ACDF™ Standalone System in the treatment of degenerative disc disease (DDD).

Mrs. Birgans’ significant depth of experience spans wide across the media and entertainment sectors; from creating content and overseeing major media productions for companies including Game Show Network, Studio USA, MTV/Viacom, Animal Planet and Billboard Music; to producing live events for brands such as Honda, Lexus and Amgen.

Severe, ongoing back pain can be severely debilitating. Some conditions can affect one’s ability to walk or carry out basic activities.

Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company focused on developing adeno-associated virus (AAV) based gene therapies for the treatment of rare inherited diseases, announced that Sue Washer, President & Chief Executive Officer and Dave Knop, Vice President of Process Development, have been awarded first place in the BioProcess International (BPI) magazine inaugural Reader’s Choice Awards

CureVac N.V. (NASDAQ:CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), today announced the start of an expansion of the ongoing Phase 1 study with its lead RNA-based cancer drug candidate, CV8102.

Qosina offers countless off-the-shelf solutions for oxygen and respiratory medical device projects, stocking a range of non-sterile respiratory care components in a variety of materials, sizes, colors and configurations

Mammogen, Inc., a women’s health startup born at the intersection of data, technology and science, and Bench International, a leading global executive search firm, jointly announce the appointment of Elizabeth Cormier-May as Chief Executive Officer and member of the board of directors of Mammogen.

Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to participate in a fireside chat at the Guggenheim Healthcare Talks 2021 Oncology Day on Thursday, February 11, 2021 at 3:30 p.m. ET.

Panel is capable of detecting 99.99% of all currently identified SARS-CoV-2 viruses based on sequence alignments and in silico analysis